News

Multiple Sclerosis


New drug shows promise in promoting MS recovery
19 January 2021

Multiple sclerosis (MS) is a neurodegenerative disease characterised by chronic infla...

Read more

Scope 66 - Why do some people respond better to MS treatment...
30 July 2018

A recent exploratory trial looking at the effect of the drug MIS416 on patients has f...

Read more

Scope 65 - Great New Zealand Trek 2018: Stage 13 completed
04 May 2018

More than 400 participants and support crew descended on the picturesque Central ...

Read more

Scope 64 - Research in focus: Multiple Sclerosis
31 October 2017

The Multiple Sclerosis team has been working with a New Zealand biomedical company...

Read more

Scope 63 - Optimizing the use of antipsychotic medicines for...
07 August 2017

Professor Anne La Flamme and her Multiple Sclerosis (MS) research group recently publ...

Read more

The Great New Zealand Trek: 9 Years and more than NZ$250,000...
04 May 2017

With an impressive 238 participants taking part this year, it’s been another successf...

Read more

The Great New Zealand Trek has raised almost a quarter of a ...
28 February 2017

Over the last 8 years, The Great New Zealand Trek has donated $245,000 to help find a...

Read more

Research Report 2016 - Multiple sclerosis
16 January 2017

A Phase Ib/IIa suitability and acceptability trial of two antipsychotic medicines, cl...

Read more

Funding brings Multiple Sclerosis clinical trial closer
04 November 2015

The journey to deliver a new (and first-ever) treatment for secondary progressive MS ...

Read more

MS drug research featured on ONE News
15 August 2014

On Thursday night, 14 August 2014, Dr Anne La Flamme's latest Multiple Sclerosis rese...

Read more

1 2 3